Xanomeline/Trospium
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Xanomeline/Trospium, covering 2025-04-11 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia [Phase 3]